ProShares S&P 500 Dividend Aristocrats ETF: (NOBL)
(Delayed Data from NYSE MKT (ex. AMEX)) As of Aug 6, 2024 03:59 PM ET
$99.90 USD
+1.11 (1.12%)
Volume: 819,870
After-Market: $99.10 -0.80 (-0.80 %) 7:58 PM ET
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$99.90 USD
+1.11 (1.12%)
Volume: 819,870
After-Market: $99.10 -0.80 (-0.80 %) 7:58 PM ET
Zacks News
Is ProShares S&P 500 Dividend Aristocrats ETF (NOBL) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for NOBL
Beat the Market the Zacks Way: Shopify, Lululemon, Telos in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Tap Both High Dividend Yield & Growth With This New ETF (DIVG)
by Sanghamitra Saha
The new ETF DIVG looks to pick about 100 stocks with the highest forecasted dividend yield growth from the eligible stocks in the index. Stocks will have a forecasted dividend yield greater than zero and continue a dividend yield every year for at least five consecutive years.
Take the Zacks Approach to Beat the Market: Pinterest, Uber, Fastenal in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Beat the Market Like Zacks: UnitedHealth, Casey's, Cencora in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Beat the Market the Zacks Way: Uber, American Tower, Intuit in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
A New Dividend-Growth ETF (TBG) Hits the Market
by Sanghamitra Saha
Dividend investing remains a popular strategy for investors amid volatility and uncertainty.
Take the Zacks Approach to Beat the Market: Shopify, American Eagle, Microsoft in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Inside the Dividend Monarchs ETF (KNGS)
by Sanghamitra Saha
The newly-launched KNGS ETF holds 30+ stocks. These stocks have been in a position to consistently raise their dividends over the last 50 years.
Beat the Market Like Zacks: Hilton, Fabrinet, Micron in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Beat the Market the Zacks Way: Novo Nordisk, Lifeway Foods, Casey's in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Take the Zacks Approach to Beat the Market: Novo Nordisk, Amgen, Fabrinet in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Is ProShares S&P 500 Dividend Aristocrats ETF (NOBL) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for NOBL
Beat the Market the Zacks Way: Novo Nordisk, MakeMyTrip, Fastenal in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Beat the Market the Zacks Way: UnitedHealth, Novo Nordisk, Check Point Software in Focus
by Santanu Roy
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Take the Zacks Approach to Beat the Market: Shopify, Caterpillar, Amgen in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Beat the Market Like Zacks: Elementis, Novo Nordisk, Amgen in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Beat the Market the Zacks Way: Automatic Data Processing, Casey's, Paysafe in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Take the Zacks Approach to Beat the Market: Shopify, Novo Nordisk, Amgen in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Beat the Market the Zacks Way: NVIDIA, Novo Nordisk, Matson in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Time for 60/40 Portfolio? ETFs in Focus
by Sanghamitra Saha
The 60/40 has proven to be one of the winning and time-tested strategies.
Beat the Market Like Zacks: Hubbell, Adobe, Nikola in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Time for High-Quality ETFs as Slowdown Worries Mount?
by Sanghamitra Saha
Due to higher rates and global economic slowdown, Wall Street may come under pressure in the near term. Quality investing then may safeguard your portfolio.
Beat the Market the Zacks Way: Caterpillar, Amgen, Broadridge Financial Solutions in Focus
by Santanu Roy
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Take the Zacks Approach to Beat the Markets: Celsius, Adobe, Curtiss-Wright in Focus
by Santanu Roy
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.